Page last updated: 2024-08-02 08:13:10

epothilone e

Description

epothilone E: structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID9806341
CHEMBL ID470478
SCHEMBL ID4126
MeSH IDM0334049

Synonyms (16)

Synonym
CHEMBL470478
epothilone e
FCCNKYGSMOSYPV-OKOHHBBGSA-N
SCHEMBL4126
AC-28332
201049-37-8
(1s,3s,7s,10r,11s,12s,16r)-7,11-dihydroxy-3-[(e)-1-[2-(hydroxymethyl)-1,3-thiazol-4-yl]prop-1-en-2-yl]-8,8,10,12-tetramethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
EX-A5461
epothilon e
uk5h6yzz8a ,
4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-3-((1e)-2-(2-(hydroxymethyl)-4-thiazolyl)-1-methylethenyl)-8,8,10,12-tetramethyl-, (1s,3s,7s,10r,11s,12s,16r)-
(-)-epothilone e
(1s,3s,7s,10r,11s,12s,16r)-7,11-dihydroxy-3-((1e)-2-(2-(hydroxymethyl)-4-thiazolyl)-1-methylethenyl)-8,8,10,12-tetramethyl-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione
unii-uk5h6yzz8a
CS-0565544
HY-147317

Bioassays (1)

Assay IDTitleYearJournalArticle
AID356712Cytotoxicity against mouse L929 cells2001Journal of natural products, Jul, Volume: 64, Issue:7
ISSN: 0163-3864
New natural epothilones from Sorangium cellulosum, strains So ce90/B2 and So ce90/D13: isolation, structure elucidation, and SAR studies.

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
desoxyepothilone bepothilonemicrotubule-stabilising agent2001200123.0low000100
epothilone bepothilone;
epoxide
antineoplastic agent;
apoptosis inducer;
microtubule-stabilising agent
2001200123.0low000100
epothilone aepothilone;
epoxide
antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
2001200123.0low000100
desoxyepothilone aepothilone2001200123.0low000100
epothilone f2001200123.0high000100
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
2001200123.0low000100
cysteamineamine;
thiol
geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
2006200618.0low000100
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1999200622.8medium002400
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2001200123.0low000100
desoxyepothilone bepothilonemicrotubule-stabilising agent2001200621.8medium000400
epothilone bepothilone;
epoxide
antineoplastic agent;
apoptosis inducer;
microtubule-stabilising agent
1999200123.5medium001300
epothilone aepothilone;
epoxide
antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
1999200622.8medium002400
desoxyepothilone aepothilone2001200621.3high000300
epothilone f2001200621.3high000300
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020